Skip to main content
Log in

Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats

Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413–420 (1995).

    Google Scholar 

  2. U. Fagerholm, M. Johansson, and H. Lennernäs. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 13:1336–1342 (1996).

    Google Scholar 

  3. W. L. Chiou. Determination of drug permeability in a flat or distended stirred intestine: Prediction of fraction dose absorbed in humans after oral administration. Int. J. Clin. Pharmacol. Ther. 32:474–482 (1994).

    Google Scholar 

  4. W. L. Chiou. The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. Biopharm. Drug. Disp. 16:71–75 (1995).

    Google Scholar 

  5. M. E. Dowty and C. R. Dietsch. Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra-and inter-rat variability. Pharm. Res. 14:1792–1797 (1997).

    Google Scholar 

  6. N. Takamatsu, L. S. Welage, N. M. Idkaidek, D. Liu, P. I-Der Lee, Y. Hayashi, J. K. Rhie, H. Lennernäs, J. L. Barnett, V. P. Shah, L. Lesko, and G. L. Amidon. Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion. Pharm. Res. 14:1127–1132 (1997).

    Google Scholar 

  7. P. Artursson and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175:880–885 (1991).

    Google Scholar 

  8. P. Artursson, K. Palm, and K. Luthman. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews 22:67–84 (1996).

    Google Scholar 

  9. P. Artursson and R. Borchardt. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm. Res. 14:1655–1658 (1997).

    Google Scholar 

  10. W. L. Chiou. The author replies to Lennernäs et al. J. Pharmacokin. Biopharm. 23:323–331 (1995).

    Google Scholar 

  11. W. L. Chiou. New perspectives on the theory of permeability and resistance in the study of drug transport and absorption. J. Pharmacokin. Biopharm. 24:433–442 (1996).

    Google Scholar 

  12. M. G. Lee and W. L. Chiou. Studies on potential factors affecting incomplete absorption of furosemide: Gastric first-pass effect. J. Pharmacokin. Biopharm. 11:623–640 (1983).

    Google Scholar 

  13. F. H. Hsu, T. Prueksaritanont, M. G. Lee, and W. L. Chiou. The phenomenon and cause of dose-dependent oral absorption of chlorothiazide in rats: Extrapolation to human data based on the body surface area concept. J. Pharmacokin. Biopharm. 15:369–383 (1987).

    Google Scholar 

  14. L. Z. Benet, S. Øie, and J. B. Schwartz. Design and Optimization of dosage regimens; Pharmacokinetic data. In A. Goodman Gilman, J. G. Hardman, L. E. Limbard, P. B. Molinoff, and R. W. Ruddon (eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edition, pp. 1707–1792, McGraw Hill, NY, 1996.

    Google Scholar 

  15. S. Chong, S. A. Dando, K. M. Soucek, and R. A. Morrison. In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system. Pharm. Res. 13:120–123 (1996).

    Google Scholar 

  16. A. Strocchi, G. Corazza, J. Furne, C. Fine, A. DiSario, G. Gasbarrini, and M. D. Levitt. Measurements of the jejunal unstirred layer in normal subjects and patients with celiac disease. Am. J. Physiol. 270:G487–G491 (1996).

    Google Scholar 

  17. Y. L. He, S. Murby, G. Warhurst, L. Gifford, D. Walker, J. Ayrton, R. Eastmond, and M. Rowland. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides. J. Pharm. Sci. 87:626–633 (1998).

    Google Scholar 

  18. D. C. Taylor, R. Grundy, and B. Loveday. Chronic dog intestinal loop model for studying drug absorption as exemplified by beta-adrenoceptor blocking agents, atenolol and propranolol. J. Pharm. Sci. 70:516–21 (1981).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiou, W.L., Barve, A. Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats. Pharm Res 15, 1792–1795 (1998). https://doi.org/10.1023/A:1011981317451

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011981317451

Navigation